Peptides for Cognitive Enhancement: Semax, Selank, Dihexa, and Cerebrolysin

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Semax boosts BDNF and dopamine for focus and memory. Selank reduces anxiety and improves learning. Dihexa is the most potent synaptogenic peptide known. Cerebrolysin contains multiple neuropeptides and is used clinically for stroke and dementia. All work through neuroplasticity pathways.

The Neuropeptide Approach to Cognitive Enhancement

Cognitive enhancement has long been pursued through stimulants and cholinergic agents. Neuropeptides represent a fundamentally different approach — rather than temporarily boosting neurotransmitter levels, they promote neuroplasticity, neurogenesis, and the formation of new synaptic connections. This distinction is crucial: peptide-based cognitive enhancement may produce lasting improvements in brain function rather than merely temporary stimulation.

Semax: BDNF Upregulation and Dopaminergic Enhancement

Semax is a synthetic heptapeptide analogue of ACTH 4-10 that has been approved in Russia for cognitive enhancement and neuroprotection since the 1990s. Its primary mechanism involves upregulation of Brain-Derived Neurotrophic Factor (BDNF) — the key protein responsible for neuroplasticity, neurogenesis, and synaptic strengthening. Users report improved focus, working memory, verbal fluency, and motivation. Typical dosing: 200–600 mcg intranasally, 1–2 times daily.

Selank: Anxiolytic and Cognitive Enhancer

Selank modulates the GABAergic system, serotonin metabolism, and enkephalin degradation. While primarily known for its anxiolytic effects, Selank also demonstrates cognitive-enhancing properties — it improves memory consolidation, attention, and learning capacity, particularly in conditions of stress or anxiety that impair cognitive function.

Dihexa: The Most Potent Synaptogenic Peptide

Dihexa activates the HGF/Met signaling pathway — one of the most potent drivers of synaptogenesis known. Animal studies have shown Dihexa to be approximately 10 million times more potent than BDNF at promoting synaptogenesis and to reverse cognitive deficits in Alzheimer's disease models. Human data is limited, but anecdotal reports describe significant improvements in cognitive clarity, memory, and verbal fluency at very low doses (1–10 mg orally).

Cerebrolysin: Multi-Peptide Neuroprotection

Cerebrolysin is a peptide preparation derived from porcine brain tissue that contains multiple low-molecular-weight neuropeptides and amino acids. It has been used clinically in Europe and Asia for decades for stroke rehabilitation, traumatic brain injury, and Alzheimer's disease. It is administered intravenously or intramuscularly in courses of 10–20 daily injections.